The role of serum biomarkers in the diagnosis of nonalcoholic fatty liver disease
Journal Title: Сучасна гастроентерологія - Year 2019, Vol 0, Issue 3
Abstract
Non-alcoholic fatty liver disease (NAFLD) is a disease characterized by liver steatosis and the ability to progress to more serious pathological conditions, including non-alcoholic steatohepatitis (NASH), fibrosis and cirrhosis of the liver. The progression of the inflammatory process, activation of fibrogenesis and collagen deposition cause the progression of the pathological process and create prerequisites for the occurrence of cirrhosis of the liver, hepatocellular carcinoma. The appearance of fibrosis is considered the most important histological change that determines the subsequent course of NASH. The puncture biopsy of the liver is recognized as the «gold standard for diagnostics» of NASH, including fibrotic changes in the liver. However, the method has a number of limitations due to the high cost and the risk of complications. Therefore, the attention of researchers focused on the search for various non-invasive biomarkers of progression of NAFLD. The latter has a number of common serum biomarkers with cardiovascular diseases, type 2 diabetes mellitus, obesity, and metabolic syndrome. Diagnosis of NAFLD by invasive methods is associated with high material costs and the threat of complications. The literature review presents a list of current biomarkers that can be used to diagnose NAFLD. The diagnostic value of cytokeratin and its combination with other promising biomarkers of steatohepatitis and liver fibrosis are considered. Identification of new serum biomarkers of steatosis and liver fibrosis will ensure timely diagnosis of NAFLD, as well as accurately assess the effectiveness of the prescribed treatment. The NAFLD diagnostic panel using serum biomarkers is minimally invasive, affordable, highly sensitive and specific, which is relevant and economically sound.
Authors and Affiliations
G. D. Fadeenko, I. E. Kushnir, T. L. Mozhina, V. M. Chernova, T. A. Solomentseva
Keywords
Related Articles
- EP ID EP615944
- DOI 10.30978/MG-2019-3-58
- Views 108
- Downloads 0
Chronic pancreatitis is an acid dependent disease. Which mark to put at the end of the sentence: interrogative, exclamation, dot or ellipsis?
Chronic pancreatitis (CP) is one of the most widespread gastroenterological diseases, the pathogenic mechanisms of which are still under investigation. The authors gave a short overview of the main stages in the research...
Human microbiome: general information and clinical significance of digestive canal eubiosis
The resent investigations demonstrate the key role of the human microbiome in the formation of homeostasis, highlight the microbiota effects on a human immune system, its development and physiology, including organo- and...
NSAID induced gastropathy in the practice of a family doctor
Nonsteroidal anti-inflammatory drugs (NSAID) are the mostly often prescribed agent for the treatment of various pathologies. However their application associated with the development of side effects, and NSAID induced ga...
The clinical-biochemical and morphological peculiarities of liver injury in patients with hematologic malignancies
Objective — to define frequency of liver infiltration by tumor cells against the background of hematologic malignancies and compare the character of pathomorphological and biochemical peculiarities of hepatotoxic reactio...
The role of proton pump inhibitors in the treatment of chronic pancreatitis. Review and own observation
The article presents analysis of the literature data on the role of acid-producing gastric function in pancreatic secretion. The indications for prescribing the proton pump inhibitors upon chronic pancreatitis are explai...